Article Versions Notes

Temesfői V, Herczeg R, Lőcsei Z, Sebestyén K, Sebestyén Z, Mangel L, Damásdi M. Should We Reconsider the Necessity of a Refinement of Prostate Cancer Risk Classification and Radiotherapy Treatment Strategy? Experiences from a Retrospective Analysis of Data from a Single Institution. Journal of Clinical Medicine. 2021; 10(1):110. https://doi.org/10.3390/jcm10010110

Temesfői, Viktória, Róbert Herczeg, Zoltán Lőcsei, Klára Sebestyén, Zsolt Sebestyén, László Mangel, and Miklós Damásdi. 2021. "Should We Reconsider the Necessity of a Refinement of Prostate Cancer Risk Classification and Radiotherapy Treatment Strategy? Experiences from a Retrospective Analysis of Data from a Single Institution" Journal of Clinical Medicine 10, no. 1: 110. https://doi.org/10.3390/jcm10010110

Temesfői, V., Herczeg, R., Lőcsei, Z., Sebestyén, K., Sebestyén, Z., Mangel, L., & Damásdi, M. (2021). Should We Reconsider the Necessity of a Refinement of Prostate Cancer Risk Classification and Radiotherapy Treatment Strategy? Experiences from a Retrospective Analysis of Data from a Single Institution. Journal of Clinical Medicine, 10(1), 110. https://doi.org/10.3390/jcm10010110